American International Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

American International Group’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-12,407	Closed	-$475K	–	4003
2016 Q1	$475K	Buy	12,407 +7,111	+134%	+$276K	﹤0.01%	2046
2015 Q4	$267K	Sell	5,296 -5,752	-52%	-$284K	﹤0.01%	2544
2015 Q3	$506K	Buy	11,048 +1,544	+16%	+$86.3K	﹤0.01%	2009
2015 Q2	$555K	Sell	9,504 -20,247	-68%	-$1.16M	﹤0.01%	2083
2015 Q1	$1.64M	Sell	29,751 -3,315	-10%	-$179K	0.01%	1281
2014 Q4	$1.66M	Sell	33,066 -2,583	-7%	-$126K	0.01%	1214
2014 Q3	$1.65M	Sell	35,649 -3,962	-10%	-$178K	0.01%	1225
2014 Q2	$1.73M	Sell	39,611 -11,562	-23%	-$468K	0.01%	1214
2014 Q1	$2.13M	Buy	51,173 +30,607	+149%	+$1.31M	0.01%	1085
2013 Q4	$762K	Buy	20,566 +19,260	+1,475%	+$691K	﹤0.01%	1688
2013 Q3	$45.8K	Buy	1,306 +426	+48%	+$14.1K	﹤0.01%	3771
2013 Q2	$25.4K	Buy	+880	New	+$25K	﹤0.01%	3842

Other funds holding PBE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

HBT

Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

American International Group's PBE Position: Q2 2016 in Review

American International Group sold out of Invesco Biotechnology & Genome ETF (PBE) in Q2 2016, closing a stake of 12,407 shares — an estimated $475K sold.

American International Group first reported a position in PBE in Q2 2013 and held it in 12 quarters. The position peaked at $2.13M in Q1 2014. 73 funds tracked by Wall St. Rank hold PBE as of Q2 2016.

American International Group reported no remaining Invesco Biotechnology & Genome ETF position as of Q2 2016 after selling out during the quarter.
American International Group sold 12,407 Invesco Biotechnology & Genome ETF shares in Q2 2016, an estimated $475K.
American International Group first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 12 quarters.
American International Group's Invesco Biotechnology & Genome ETF position peaked at $2.13M in Q1 2014.
73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.